30
Participants
Start Date
November 30, 2008
Primary Completion Date
October 31, 2009
Study Completion Date
October 31, 2009
clevidipine
Clevidipine (0.5mg/mL in 20% lipid emulsion) was administered as an IV bolus (\<5 sec) by rapid injection for Bolus 1 and for Bolus 2, if second bolus dose was administered, directly into a peripheral venous catheter followed by a normal saline flush (10mL).
Hospital of the University of Pennsylvania, Philadelphia
Massachusetts General Hospital, Harvard Medical School, Boston
Lead Sponsor
The Medicines Company
INDUSTRY